[Therapy with perindopril: organoprotection, not just the antihypertensive effect]
- Kardiologiia. 2012;52(12):80-3.
Perindopril is one of the most prescribed inhibitors of angiotensin converting enzyme, has a large evidence base, which allows to use it in patients with hypertension, diabetes mellitus type 2, coronary heart disease and chronic heart failure. In this review, the author focused on the evidence of organoprotecting properties of perindopril that lie outside lowering blood pressure.
-
Cat. No.Product NameDescriptionTargetResearch Area
-